Literature DB >> 20085998

Application of an in vitro drug screening assay based on the release of phosphoglucose isomerase to determine the structure-activity relationship of thiazolides against Echinococcus multilocularis metacestodes.

Britta Stadelmann1, Sabrina Scholl, Joachim Müller, Andrew Hemphill.   

Abstract

OBJECTIVES: The disease alveolar echinococcosis (AE), caused by the larval stage of the cestode Echinococcus multilocularis, is fatal if treatment is unsuccessful. Current treatment options are, at best, parasitostatic, and involve taking benzimidazoles (albendazole, mebendazole) for the whole of a patient's life. In conjunction with the recent development of optimized procedures for E. multilocularis metacestode cultivation, we aimed to develop a rapid and reliable drug screening test, which enables efficient screening of a large number of compounds in a relatively short time frame.
METHODS: Metacestodes were treated in vitro with albendazole, the nitro-thiazole nitazoxanide and 29 nitazoxanide derivatives. The resulting leakage of phosphoglucose isomerase (PGI) activity into the medium supernatant was measured and provided an indication of compound efficacy.
RESULTS: We show that upon in vitro culture of E. multilocularis metacestodes in the presence of active drugs such as albendazole, the nitro-thiazole nitazoxanide and 30 different nitazoxanide derivatives, the activity of PGI in culture supernatants increased. The increase in PGI activity correlated with the progressive degeneration and destruction of metacestode tissue in a time- and concentration-dependent manner, which allowed us to perform a structure-activity relationship analysis on the thiazolide compounds used in this study.
CONCLUSIONS: The assay presented here is inexpensive, rapid, can be used in 24- and 96-well formats and will serve as an ideal tool for first-round in vitro tests on the efficacy of large numbers of antiparasitic compounds.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20085998     DOI: 10.1093/jac/dkp490

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  23 in total

1.  Small-molecule activators of TMEM16A, a calcium-activated chloride channel, stimulate epithelial chloride secretion and intestinal contraction.

Authors:  Wan Namkung; Zhen Yao; Walter E Finkbeiner; A S Verkman
Journal:  FASEB J       Date:  2011-08-11       Impact factor: 5.191

2.  Sensitive in vitro system to assess morphological and biochemical effects of praziquantel and albendazole on Taenia solium cysts.

Authors:  S Mahanty; A Paredes; M Marzal; E Gonzalez; S Rodriguez; P Dorny; C Guerra-Giraldez; H H Garcia; T Nash
Journal:  Antimicrob Agents Chemother       Date:  2010-11-01       Impact factor: 5.191

3.  Biological activity of modified and exchanged 2-amino-5-nitrothiazole amide analogues of nitazoxanide.

Authors:  T Eric Ballard; Xia Wang; Igor Olekhnovich; Taylor Koerner; Craig Seymour; Paul S Hoffman; Timothy L Macdonald
Journal:  Bioorg Med Chem Lett       Date:  2010-05-18       Impact factor: 2.823

4.  In vitro efficacy of dicationic compounds and mefloquine enantiomers against Echinococcus multilocularis metacestodes.

Authors:  Britta Stadelmann; Tatiana Küster; Sabrina Scholl; Fabienne Barna; Christian Kropf; Jennifer Keiser; David W Boykin; Chad E Stephens; Andrew Hemphill
Journal:  Antimicrob Agents Chemother       Date:  2011-07-18       Impact factor: 5.191

5.  Two Novel Calcium-Dependent Protein Kinase 1 Inhibitors Interfere with Vertical Transmission in Mice Infected with Neospora caninum Tachyzoites.

Authors:  Joachim Müller; Adriana Aguado-Martínez; Vreni Balmer; Dustin J Maly; Erkang Fan; Luis-Miguel Ortega-Mora; Kayode K Ojo; Wesley C Van Voorhis; Andrew Hemphill
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

6.  Progress in the pharmacological treatment of human cystic and alveolar echinococcosis: Compounds and therapeutic targets.

Authors:  Mar Siles-Lucas; Adriano Casulli; Roberto Cirilli; David Carmena
Journal:  PLoS Negl Trop Dis       Date:  2018-04-20

7.  In vitro and in vivo efficacies of mefloquine-based treatment against alveolar echinococcosis.

Authors:  Tatiana Küster; Britta Stadelmann; Corina Hermann; Sabrina Scholl; Jennifer Keiser; Andrew Hemphill
Journal:  Antimicrob Agents Chemother       Date:  2010-12-06       Impact factor: 5.191

8.  Quantitative screening for anticestode drugs based on changes in baseline enzyme secretion by Taenia crassiceps.

Authors:  Siddhartha Mahanty; Elise M Madrid; Theodore E Nash
Journal:  Antimicrob Agents Chemother       Date:  2012-12-10       Impact factor: 5.191

9.  In vitro and in vivo activities of dicationic diguanidino compounds against Echinococcus multilocularis metacestodes.

Authors:  Tatiana Küster; Nadja Kriegel; David W Boykin; Chad E Stephens; Andrew Hemphill
Journal:  Antimicrob Agents Chemother       Date:  2013-05-28       Impact factor: 5.191

10.  In vivo and in vitro efficacy of crocin against Echinococcus multilocularis.

Authors:  Chuanchuan Liu; Haining Fan; Lu Guan; Ri-Li Ge; Lan Ma
Journal:  Parasit Vectors       Date:  2021-07-13       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.